REFERENCES
- Tos M, Charabi S, Thomsen J. Incidence of vestibular schwannomas. Laryngoscope 1999; 109: 736–40.
- Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971; 285: 1182–6.
- Charabi S, Rygaard J, Klinken L, Tos M, Thomsen J. Subcutaneous growth of human acoustic schwannomas in athymic nude mice. Acta Otolaryngol (Stockh) 1994; 114: 399–405.
- Lee JK, Kim TS, Chiocca EA, Medhkour A, Martuza RL. Growth of human schwannomas in the subrenal capsule of the nude mouse. Neurosurgery 1990; 26: 598–605.
- Cardillo MR, Filipo R, Monini S, Aliotta N, Barbara M. Transforming growth factor-beta1 expression in human acoustic neuroma. Am J Otol 1999; 20: 65–8.
- Huang D, Rutkowski JL, Brodeur GM, et al. Schwann cell-conditioned medium inhibits angiogenesis in vitro and in vivo. Med Pediatr Oncol 2000; 35: 590–2.
- Huang D, Rutkowski JL, Brodeur GM, et al. Schwann cell-conditioned medium inhibits angiogenesis. Cancer Res 2000; 60: 5966–71.
- Chantry D, Turner M, Abhey E, Feldmann M. Modulation of cytokine production by transforming growth factor-β1. J Immunol 1989; 142: 4295–300.
- Dillard DG, Cohen C, Muller S, et al. Immunolocalization of activated transforming growth factor-βl in juvenile nasopharyngeal angiofibroma. Arch Otolaryngol Head Neck Surg 2000; 126: 723–5.
- Gorsch SM, Memoli VA, Stukel TA, Gold LI, Arrick BA. Immunohistochemical staining for transforming growth factor beta 1 associates with disease progression in human breast cancer. Cancer Res 1992; 52: 6949–52.
- Roberts AB, Sporn MB. Transforming growth factor-β1. Adv Cancer Res 1998; 51: 107–45.
- Ferrara N. Molecular and biological properties of vascular endothelial growth factor. J Mol Med 1999; 77: 527–43.
- Risau W. Mechanisms of angiogenesis. Nature 1997; 386: 671–4.
- Nishikawa R, Cheng SV, Nagashima R, Huang HJ, Cavenee WK, Matsutani M. Expression of vascular endothelial growth factor in human brain tumors. Acta Neuropathol 1998; 96: 453–62.
- Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/Vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995; 146: 1029–39.
- Folkman J. New perspectives in clinical oncology from angiogenesis research. Eur J Cancer 1996; 32: 2534–9.
- Folkman J. Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N Engl J Med 1995; 333: 1757–63.
- Macluskey M, Chandrachud LM. Apoptosis, proliferation and angiogenesis in oral tissues. Possible relevance to tumor progression. J Pathol 2000; 19: 368–75.
- Pietsch M, Ralter MM, Wolf HK, et al. Expression and distribution of vascular endothelial growth factor protein in human brain tumors. Acta Neuropathol 1997; 93: 109–17.
- Bedavanija A, Brieger J, Lehr HA, Maurer J, Mann WJ. Association of proliferative activity and size in acoustic neuroma: implications for timing of surgery. J Neurosurg 2003 Apr; 98 (4): 807–11.
- Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57–70.
- Coste A, Wang QP, Thuraral FR, et al. Epithelial cell proliferation in nasal polyps could be up-regulated by platelet-derived growth factor. Laryngoscope 1996; 106: 578–83.
- Simon M, Grone HJ, Johren O, et al. Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney. Am J Physiol 1995; 268: 240–50.